Published in Nat Genet on January 31, 2010
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A (2012) 4.10
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science (2011) 3.30
Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics (2011) 2.53
The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med (2012) 2.42
Transcriptional variation in the malaria parasite Plasmodium falciparum. Genome Res (2012) 2.15
Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Am J Trop Med Hyg (2012) 1.97
In vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genes. PLoS One (2012) 1.74
Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. PLoS Pathog (2010) 1.71
Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum. PLoS Genet (2011) 1.68
PfCRT and its role in antimalarial drug resistance. Trends Parasitol (2012) 1.63
Hybrid selection for sequencing pathogen genomes from clinical samples. Genome Biol (2011) 1.61
Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite. Proc Natl Acad Sci U S A (2012) 1.58
Population genomic scan for candidate signatures of balancing selection to guide antigen characterization in malaria parasites. PLoS Genet (2012) 1.55
Evolution of eukaryotic microbial pathogens via covert sexual reproduction. Cell Host Microbe (2010) 1.50
Imputation-based population genetics analysis of Plasmodium falciparum malaria parasites. PLoS Genet (2015) 1.47
Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in Papua New Guinea, a region of intense perennial transmission. Malar J (2010) 1.47
How can we identify parasite genes that underlie antimalarial drug resistance? Pharmacogenomics (2011) 1.44
Harnessing genomics and genome biology to understand malaria biology. Nat Rev Genet (2012) 1.41
An adaptable two-color flow cytometric assay to quantitate the invasion of erythrocytes by Plasmodium falciparum parasites. Cytometry A (2010) 1.39
Drug-Resistant Malaria: The Era of ACT. Curr Infect Dis Rep (2010) 1.33
Applied genomics: data mining reveals species-specific malaria diagnostic targets more sensitive than 18S rRNA. J Clin Microbiol (2011) 1.32
Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum. Antimicrob Agents Chemother (2012) 1.30
High recombination rates and hotspots in a Plasmodium falciparum genetic cross. Genome Biol (2011) 1.27
Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites. Genome Res (2010) 1.27
An optimized microarray platform for assaying genomic variation in Plasmodium falciparum field populations. Genome Biol (2011) 1.24
Challenges and prospects for malaria elimination in the Greater Mekong Subregion. Acta Trop (2011) 1.21
Interactive transcriptome analysis of malaria patients and infecting Plasmodium falciparum. Genome Res (2014) 1.20
Population genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assay. PLoS One (2011) 1.13
Comparative genome analysis of two Cryptosporidium parvum isolates with different host range. Infect Genet Evol (2012) 1.09
Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya. Sci Rep (2013) 1.07
Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure. Antimicrob Agents Chemother (2011) 1.04
Malaria drug resistance: new observations and developments. Essays Biochem (2011) 1.03
Improving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugs. PLoS Comput Biol (2013) 1.00
Antimalarial drug resistance in Africa: key lessons for the future. Ann N Y Acad Sci (2015) 1.00
Malaria life cycle intensifies both natural selection and random genetic drift. Proc Natl Acad Sci U S A (2013) 0.99
Discovery of new antimalarial chemotypes through chemical methodology and library development. Proc Natl Acad Sci U S A (2011) 0.99
Drug resistance genomics of the antimalarial drug artemisinin. Genome Biol (2014) 0.95
Population structuring of multi-copy, antigen-encoding genes in Plasmodium falciparum. Elife (2012) 0.95
SNP genotyping identifies new signatures of selection in a deep sample of West African Plasmodium falciparum malaria parasites. Mol Biol Evol (2012) 0.95
Application of genomics to field investigations of malaria by the international centers of excellence for malaria research. Acta Trop (2011) 0.95
Genetic mapping identifies novel highly protective antigens for an apicomplexan parasite. PLoS Pathog (2011) 0.94
Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter. Mol Microbiol (2015) 0.90
Genomics and integrated systems biology in Plasmodium falciparum: a path to malaria control and eradication. Parasite Immunol (2012) 0.90
Recent Progress in Functional Genomic Research in Plasmodium falciparum. Curr Genomics (2010) 0.90
Degrees of chloroquine resistance in Plasmodium - is the redox system involved? Int J Parasitol Drugs Drug Resist (2012) 0.89
Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach. Malar J (2012) 0.87
Analysis of malaria parasite phenotypes using experimental genetic crosses of Plasmodium falciparum. Int J Parasitol (2012) 0.87
Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar. J Antimicrob Chemother (2014) 0.85
Recurrent bottlenecks in the malaria life cycle obscure signals of positive selection. Parasitology (2014) 0.84
Protein-based signatures of functional evolution in Plasmodium falciparum. BMC Evol Biol (2011) 0.84
Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease. Public Health Genomics (2014) 0.84
A HECT ubiquitin-protein ligase as a novel candidate gene for altered quinine and quinidine responses in Plasmodium falciparum. PLoS Genet (2014) 0.82
Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance. MBio (2016) 0.81
Comparison of genomic signatures of selection on Plasmodium falciparum between different regions of a country with high malaria endemicity. BMC Genomics (2015) 0.81
Whole Genome Sequencing of Field Isolates Reveals Extensive Genetic Diversity in Plasmodium vivax from Colombia. PLoS Negl Trop Dis (2015) 0.81
Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi. Malar J (2016) 0.81
Pharmacological considerations in the design of anti-malarial drug combination therapies - is matching half-lives enough? Malar J (2014) 0.80
Drug combination therapy increases successful drug repositioning. Drug Discov Today (2016) 0.80
Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance. Pathogens (2013) 0.80
Genome-wide polymorphisms and development of a microarray platform to detect genetic variations in Plasmodium yoelii. Mol Biochem Parasitol (2014) 0.79
Whole genome capture of vector-borne pathogens from mixed DNA samples: a case study of Borrelia burgdorferi. BMC Genomics (2015) 0.79
Molecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance Transporter. PLoS Pathog (2016) 0.78
Genetics of chloroquine-resistant malaria: a haplotypic view. Mem Inst Oswaldo Cruz (2013) 0.78
Revealing the molecular signatures of host-pathogen interactions. Genome Biol (2011) 0.77
PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers. Sci Rep (2016) 0.76
Improving the role and contribution of pharmacokinetic analyses in antimalarial drug clinical trials. Antimicrob Agents Chemother (2014) 0.76
Malaria parasite genome scan: insights into antimalarial resistance. Parasitol Res (2010) 0.76
Reduced deformability of parasitized red blood cells as a biomarker for anti-malarial drug efficacy. Malar J (2015) 0.76
Chemical genomics for studying parasite gene function and interaction. Trends Parasitol (2013) 0.76
Genome-wide association analysis identifies genetic loci associated with resistance to multiple antimalarials in Plasmodium falciparum from China-Myanmar border. Sci Rep (2016) 0.76
Exceptionally long-range haplotypes in Plasmodium falciparum chromosome 6 maintained in an endemic African population. Malar J (2016) 0.75
Heavy path mining of protein-protein associations in the malaria parasite. Methods (2015) 0.75
Genome-wide association studies in Plasmodium species. BMC Biol (2010) 0.75
Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia. Proc Natl Acad Sci U S A (2016) 0.75
A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection. G3 (Bethesda) (2017) 0.75
Advances in genetics and genomics: use and limitations in achieving malaria elimination goals. Pathog Glob Health (2015) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Inference of population structure using multilocus genotype data. Genetics (2000) 147.76
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
A map of recent positive selection in the human genome. PLoS Biol (2006) 29.19
Detecting recent positive selection in the human genome from haplotype structure. Nature (2002) 22.00
Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med (2008) 17.65
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature (2002) 12.09
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell (2000) 10.72
Intercontinental spread of pyrimethamine-resistant malaria. Science (2004) 8.73
Signals of recent positive selection in a worldwide sample of human populations. Genome Res (2009) 8.38
Multiplexed genotyping with sequence-tagged molecular inversion probes. Nat Biotechnol (2003) 7.02
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol (2005) 4.92
Effectiveness of antimalarial drugs. N Engl J Med (2005) 4.83
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg Infect Dis (2008) 4.68
Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans R Soc Trop Med Hyg (2000) 4.63
Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell (1997) 3.98
Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome. Nat Genet (2006) 3.45
Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci U S A (1994) 3.45
Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol (2004) 3.30
Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol (2003) 3.26
Recombination hotspots and population structure in Plasmodium falciparum. PLoS Biol (2005) 2.67
Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics (1998) 2.36
Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biol (2009) 2.23
Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am J Trop Med Hyg (1998) 1.92
Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J Biol Chem (2008) 1.86
SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes. J Exp Med (2005) 1.83
Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping. Am J Trop Med Hyg (2008) 1.79
In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1993) 1.57
Genome-wide compensatory changes accompany drug- selected mutations in the Plasmodium falciparum crt gene. PLoS One (2008) 1.36
Drug resistance and genetic mapping in Plasmodium falciparum. Curr Genet (2008) 1.36
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med (2008) 17.65
Typhoid fever. N Engl J Med (2002) 12.96
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet (2012) 11.82
A metagenomic survey of microbes in honey bee colony collapse disorder. Science (2007) 11.72
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med (2004) 10.14
Variation in genome-wide mutation rates within and between human families. Nat Genet (2011) 8.84
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med (2005) 8.36
A coalescent-based method for detecting and estimating recombination from gene sequences. Genetics (2002) 7.41
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis (2012) 6.94
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol (2006) 6.34
Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol (2010) 6.28
A major genome region underlying artemisinin resistance in malaria. Science (2012) 6.25
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis (2013) 6.06
Mixed-species malaria infections in humans. Trends Parasitol (2004) 6.01
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One (2009) 5.81
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J (2011) 5.65
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol (2005) 5.18
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A (2002) 5.07
Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A (2002) 4.85
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med (2005) 4.65
Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg (2007) 4.58
Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A (2010) 4.50
Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med (2005) 4.47
Manslaughter by fake artesunate in Asia--will Africa be next? PLoS Med (2006) 4.46
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop Med Int Health (2006) 4.44
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis (2007) 4.35
Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J (2008) 4.33
Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med (2008) 4.33
Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med Int Health (2006) 4.32
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J (2009) 4.25
The threat of artemisinin-resistant malaria. N Engl J Med (2011) 4.15
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis (2006) 4.14
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet (2004) 4.14
Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A (2012) 4.10
Early origin and recent expansion of Plasmodium falciparum. Science (2003) 4.07
Counterfeit anti-infective drugs. Lancet Infect Dis (2006) 3.91
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet (2006) 3.90
Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis (2005) 3.89
Rickettsial infections and fever, Vientiane, Laos. Emerg Infect Dis (2006) 3.87
Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci U S A (2002) 3.83
Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. PLoS Med (2006) 3.83
High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis (2010) 3.81
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis (2011) 3.78
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet (2004) 3.72
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68
A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. Mol Biol Evol (2003) 3.67
Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis (2010) 3.59
Artemisinin-resistant malaria in Asia. N Engl J Med (2009) 3.58
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome. Nat Genet (2006) 3.45
RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell (2008) 3.44
Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A (2006) 3.33
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science (2011) 3.30
Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol (2004) 3.30
Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol (2003) 3.26
Differential prevalence of Plasmodium infections and cryptic Plasmodium knowlesi malaria in humans in Thailand. J Infect Dis (2009) 3.25
Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis (2010) 3.21
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J (2009) 3.19
The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med (2005) 3.15
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin Infect Dis (2005) 3.15
In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J (2012) 3.13
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13